New Drugs for Type 2 Diabetes: New Hopes and New Concerns About the Skeleton

New Drugs for Type 2 Diabetes: New Hopes and New Concerns About the Skeleton

Diabetes is an important public health concern associated with significant morbidity, premature mortality, and health-system costs. Its global prevalence has nearly doubled since 1980, rising from 4.7% to 8.5% in the adult population in 2014. Additionally, the number of diabetic adults in the world...

Full description

Bibliographic Details
Main Author: Zehra Berberoglu
Format: Article
Language:English
Published: European Medical Journal 2016-10-01
Series:European Medical Journal Diabetes
Subjects:
skeletal health
glucagon-like peptide-1 receptor agonists
dipeptidyl peptidase-4 inhibitors
sodium-glucose cotransporter 2 inhibitors
Online Access:https://www.emjreviews.com/diabetes/article/editors-pick-new-drugs-for-type-2-diabetes-new-hopes-and-new-concerns-about-the-skeleton/

Internet

https://www.emjreviews.com/diabetes/article/editors-pick-new-drugs-for-type-2-diabetes-new-hopes-and-new-concerns-about-the-skeleton/

Similar Items